Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer

ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading

(2010) Paul Mak et al.   CANCER CELL

Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion

(2010) Yuet-Kin Leung et al.   ENDOCRINE-RELATED CANCER

Estrogen receptor-  activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNF  mediated

(2010) S. J. McPherson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of a Biphasic Role for Genistein in the Regulation of Prostate Cancer Growth and Metastasis

(2009) L. H. El Touny et al.   CANCER RESEARCH

Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways

(2009) M. Puhr et al.   CANCER RESEARCH

CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells

(2009) Ming Chen et al.   CARCINOGENESIS

Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells

(2009) Frédéric R Santer et al.   ENDOCRINE-RELATED CANCER

Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

(2009) Simona Nanni et al.   JOURNAL OF CLINICAL INVESTIGATION

CBP Is a Dosage-Dependent Regulator of Nuclear Factor-κB Suppression by the Estrogen Receptor

(2007) Kendall W. Nettles et al.   MOLECULAR ENDOCRINOLOGY